Earnings Feed
Start Free
Home/Filings/4/0001415889-24-028563
4//SEC Filing

MIDDLETON FRED A 4

Accession 0001415889-24-028563

CIK 0001534133other
View on SEC.govCompany Profile

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 7:12 PM ET

Size

14.5 KB

Accession

0001415889-24-028563

Insider Transaction Report

Form 4
Period: 2024-12-06
CalciMedica, Inc.CALC
MIDDLETON FRED A
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2024-12-06$2.65/sh+4,800$12,720→ 36,514 total
Holdings

  • Common Stock

    (indirect: By LLC)
    8,176

  • Common Stock

    (indirect: By Sanderling Ventures Management VII)
    30,292

  • Common Stock

    (indirect: By Sanderling VI Beteligungs GmbH & Co KG)
    7,456

  • Common Stock

    (indirect: By Sanderling Venture Partners VI Co-Investment Fund, L.P.)
    814,300

  • Common Stock

    (indirect: By Sanderling Venture Partners VI, LP)
    946,744

  • Common Stock

    (indirect: By Sanderling Ventures Management VI)
    22,479

  • Common Stock

    (indirect: By Partnership)
    8,884

  • Common Stock

    (indirect: By Sanderling Ventures VII, L.P.)
    435,148

  • Common Stock

    (indirect: By Sanderling Ventures VII (Canada), L.P.)
    114,260

  • Common Stock

    (indirect: By Sanderling Ventures VII Annex Fund, L.P.)
    27,609
Footnotes (5)
  • [F1]The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI Co-Investment Fund, LP ("SVP VI Co-Investment, LP", together with Sanderling Venture Partners VI, LP., Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (the "Sanderling VI Securities"). The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  • [F2]The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VI Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F3]The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Ventures VII, LP ("SVP VII, LP", together with Sanderling Ventures Management VII, Sanderling Ventures VII (Canada), L.P. and Sanderling Ventures VII Annex Fund, L.P., the "Sanderling VII Securities"). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F4]The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VII Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F5]The Reporting Person is a managing member of Golden Triangle Ventures LLC and may be deemed to beneficially own the securities of the Issuer held by Golden Triangle Ventures LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

CalciMedica, Inc.

CIK 0001534133

→
Entity typeother

Related Parties

1
  • filerCIK 0001267959

Filing Metadata

Form type
4
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 7:12 PM ET
Size
14.5 KB
View on SEC.gov